Question 1

Does Polar Capital Holdings own MLTX stock?

Accepted Answer

No. Polar Capital Holdings exited its MLTX (MoonLake Immunotherapeutics) position in Q3 2025. Its Q2 2025 13F listed 247,500 shares worth $11.7M.

Question 2

How many shares of MLTX does Polar Capital Holdings own?

Accepted Answer

None since Q3 2025, when Polar Capital Holdings exited the position. Its Q2 2025 13F listed 247,500 shares worth $11.7M.

Question 3

What is Polar Capital Holdings' MLTX position worth?

Accepted Answer

Polar Capital Holdings' MLTX position was worth $11.7M in its Q2 2025 13F, before the exit in Q3 2025.

Question 4

Is Polar Capital Holdings buying or selling MLTX?

Accepted Answer

In Q3 2025, Polar Capital Holdings exited its entire MLTX position.

Question 5

When did Polar Capital Holdings first buy MLTX?

Accepted Answer

Polar Capital Holdings first reported MLTX in its Q4 2022 13F and listed it in 11 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2025-Q3 Latest	Exited	0	-100.0%	$0	0.0%	$6.24	0
2025-Q2	Decreased	247,500	-77.5%	$11.7M	0.1%	$47.52	0
2025-Q1	Unchanged	1.1M	0.0%	$43M	0.3%	$39.86	0
2024-Q4	Increased	1.1M	+120.0%	$59.6M	0.3%	$53.02	57
2024-Q3	Decreased	500,000	-26.3%	$25.2M	0.1%	$49.40	0
2024-Q2	Decreased	678,169	-21.0%	$29.8M	0.2%	$43.97	0
2024-Q1	Decreased	857,957	-8.4%	$43.1M	0.2%	$50.23	0
2023-Q4	Decreased	937,115	-0.2%	$56.6M	0.3%	$60.39	0
2023-Q3	Decreased	939,012	-41.9%	$53.5M	0.4%	$57.00	0
2023-Q2	Increased	1.6M	+84.3%	$82.4M	0.4%	$51.08	55
2023-Q1	Unchanged	876,377	0.0%	$18.7M	0.1%	$21.85	0
2022-Q4	New	876,377	-	$9.2M	0.1%	$10.50	38